Burlingame, Nov. 07, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global macrophage markers market is estimated to be valued at US$ 256.2 million in 2023 and is expected to exhibit a CAGR of 6.5% during the forecast period (2022-2030).
Macrophage markers are important tools widely used for research and diagnostics in cancer biology, immunology, and infectious diseases. The macrophage markers is witnessing strong growth on the account of growing research activities in oncology, immunology, and infectious diseases. Thus growing prevalence of chronic disease such as autoimmune disorder and cancers is propelling macrophage market growth.
Request Sample of the Report on Macrophage Markers Market Forecast 2030:
https://www.coherentmarketinsights.com/insight/request-sample/5945
Market Drivers:
Growing prevalence of chronic disease such as cancer to augment market growth
Global burden of chronic disease is a key factor propelling macrophage markers market growth. Macrophage markers are crucial for various stages of these diseases. This is creating demand for macrophage. According to the World Health Organization, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020 (1). The most common in 2020 (in terms of new cases of cancer) were: breast (2.26 million cases); lung (2.21 million cases); prostate (1.41 million cases); and stomach (1.09 million cases)
Growing research in immunology to propel market growth
Increasing number of research in the field of immunology owing to the growing need to understand the role of macrophages in various diseases such as autoimmune disorders, cancers, and infectious diseases is fueling macrophages markers market growth. Macrophages are important for increasing the efficacy of research. Thus, growing research and development activities in immunology is expected to propel market growth.
Macrophage Marker Market Report Coverage
| Report Coverage | Details |
| Forecast Period | 2023 to 2030 |
| Forecast Period 2023 to 2030 CAGR | 6.5% |
| Market Size in 2023 | $256.2 million |
| 2030 Value Projection | $398.2 million |
| Base Year | 2022 |
| Historical Data for | 2017 to 2021 |
| Segments covered | • By Marker Type, By Application, By Disease Scale, By End User |
| Growth Drivers | • Increasing Research in Immunology • Growing Prevalence of Chronic Diseases • Technological Advancements • Personalized Medicine Approach |
Market Key Developments:
BD Biosciences, a medical technology company, offers BD FACS Canto Human Macrophage Panel. This panel includes 12 antibodies that target specific macrophage markers, allowing researchers to profile and identify different types of macrophages in a single experiment.
On February 14, 2023, Bio-Techne Corporation, a biotechnology company in partnership with Cell Signaling Technology (CST), a life science company, announced the addition of simple western validation to CST antibodies. This will allow researchers in various disciplines an easier way to study important molecular signaling pathways on validated platform. Obtaining accurate data efficiently and quickly is key to advancing drug discovery and development. This partnership will further allow for an expanded menu of Simple Western validated antibodies for various targets across multiple disciplines.
Buy Now & Get Exclusive Discount On This Report: https://www.coherentmarketinsights.com/insight/buy-now/5945
Market Restrain:
Regulatory hurdles and high costs are expected to restrict market growth
The cost of high-quality macrophage markers is a obstacle, especially for smaller research institutions and laboratories. Moreover, producing and marketing macrophage markers need compliance with regulatory guidelines, which is a complex and time-consuming process. Thus, regulatory barriers and high costs are expected to restrict the market growth.
Market Opportunities:
Advent of novel macrophage markers to present significant market opportunities
Key players in the market are introducing novel markers in order to meet the growing demand. Moreover, thers is an opportunity for markers in diagnostic applications that can support early diagnosis and monitoring of diseases such as inflammatory disorders, cancer, and infectious diseases. Furthermore, advancement in imaging technology is further expected to uplift the market growth in the near future.
Key Trends and Analysis of the Global Macrophage Markers Market:
Growing shift towards personalized approaches is a recent trend in the global market. Macrophage markers is used to identify specific macrophage populations and their functional characteristics, providing valuable information for personalized treatment decisions. Thus, growing adoption of personalized medicine is fueling the demand for macrophage markers.
Request Customization of this Report: https://www.coherentmarketinsights.com/insight/request-customization/5945
Key Market Takeaways:
Global macrophage markers market is expected to exhibit a CAGR of 6.5% during the forecast period, owing to growing prevalence of chronic disease, increasing research in immunology, and development of novel biomarkers.
On the basis of Marker Type, CD68 segment is expected to hold a dominant position, as it is a glycoprotein and is commonly used as a marker for macrophages.
On the basis of Application, Immunohistochemistry (IHC) segment is expected to hold a dominant position, as macrophages is important component in immunology research to understand the various stages of disease.
On the basis of Disease Area, Oncology segment is expected to hold a dominant position, owing to the growing prevalence of cancers worldwide.
On the basis of End User, research institutes and academic centers segment is expected to hold a dominant position, owing to the increasing demand for macrophages from immunology research.
On the basis of region, North America is expected to hold a dominant position over the forecast period, due to increasing demand for cell-based therapies, growing prevalence of cancer and chronic disease, and increasing research activities in immunology.
Key players operating in the global macrophage markers market include Abcam plc, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., BD Biosciences, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., BioLegend, Inc., Merck KGaA, Novus Biologicals, LLC, R&D Systems, Inc. (a Bio-Techne brand), Santa Cruz Biotechnology, Inc., Beckman Coulter, Inc., Miltenyi Biotec GmbH, GeneTex, Inc., MBL International Corporation.
Detailed Segmentation:
- Global Macrophage Marker Market, By Marker Type:
- CD68
- CD163
- CD206
- CD14
- CD11b
- CD64
- CD11c
- Others
- Global Macrophage Marker Market, By Application:
- Immunohistochemistry (IHC)
- Flow Cytometry
- Immunofluorescence (IF)
- Polymerase Chain Reaction (PCR)
- Others
- Global Macrophage Marker Market, By Disease Area:
- Oncology
- Infectious Diseases
- Autoimmune Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Others
- Global Macrophage Marker Market, By End User:
- Research Institutes and Academic Centers
- Pharmaceutical and Biotechnology Companies
- Clinical Laboratories
- Others
- Global Macrophage Marker Market, By Region:
- North America
- U.S.
- Canada
- Europe
- Germany
- Italy
- U.K.
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- Australia
- India
- ASEAN
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- Israel
- South Africa
- Rest of Middle East & Africa
- North America
Related Market Intelligence Reports:
Integrase Inhibitors Market, By Drug Class (First-Generation Integrase Inhibitors, Second-Generation Integrase Inhibitors, Others), By Indication (HIV Infection, Other Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa), By End User (Hospitals and Clinics, Research Institutes, Others), and By Geography, Market Size And Share Analysis - Growth Trends And Forecasts (2023 - 2030)
Phenobarbital Market, By Indication (Epilepsy, Neonatal Seizures), By Dosage Form (Tablets, Injectable Formulations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Geography, Market Size And Share Analysis - Growth Trends And Forecasts (2023 - 2030)
Neuroplasticity Market, By Product Type (Software-Based Solutions, Hardware-Based Solutions), By Application (Stroke Rehabilitation, Traumatic Brain Injury (TBI) Rehabilitation, Neurodegenerative Disorders, Learning and Memory Enhancement, Mental Health Disorders), By End User (Hospitals and Clinics, Research Institutes and Academic Centers, Pharmaceutical and Biotechnology Companies, Others), By Geography, Market Size And Share Analysis - Growth Trends And Forecasts (2023 - 2030)
Browse through Coherent Market Insights Pharmaceutical Research Reports.
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
